Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Stem cell therapy independent of stemness.
Cannabinoid modulation of neuroinflammatory disorders.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Clutter management for individuals with multiple sclerosis.
MicroRNA in neurodegenerative drug discovery: the way forward?
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Longitudinal associations between MRI and cognitive changes in very early MS.
The molecular physiology of the axo-myelinic synapse.
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Editorial: Plasticity in Multiple Sclerosis: From Molecular to System Level, from Adaptation to Maladaptation.
Are Hsp70 protein expression and genetic polymorphism implicated in multiple sclerosis inflammation?
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study.
Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
Impaired social cognition in multiple sclerosis.
Pages
« first
‹ previous
…
480
481
482
483
484
485
486
487
488
…
next ›
last »